Ongoing Concerns Surrounding Birth Control Drugs Yaz, Yasmin and Ocella
A recent news report by the Los Angeles Times highlights ongoing concerns regarding the safety of the birth-control drugs Yaz, Yasmin, and Ocella, the generic version. When these drugs first came on the market, it was believed that they would be safer than existing birth control brands because they contained a different type of synthetic progestin. However, as of mid-February 2010, about 1,100 lawsuits have been filed in the U.S. against Bayer, the manufacturer of the birth control drugs. It is believed that the ingredient drospirenone in Yaz and Yasmin is leading to a higher risk of blood clots, heart attacks and gallbladder disease than other types of birth control.
There is contradictory research regarding the safety of Yaz and Yasmin. Currently, the FDA is continuing their research into the safety concerns of these drugs. In 2009, the British Medical Journal published two studies finding that the ingredient drospirenone was more likely to cause blood clots than other types of synthetic progestins. Thesestudies concluded that birth control pills containing drospirenone lead to a higher risk of blood clots.
Contact an Experienced Attorney
If you or a loved one has suffered from blood clots or gallbladder problems as a result of taking Yaz, Yasmin, or Ocella, contact our law firm today. We will provide you with a free no-obligation consultation.